{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:23:05Z","timestamp":1778948585803,"version":"3.51.4"},"reference-count":27,"publisher":"SAGE Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["THC"],"published-print":{"date-parts":[[2024,11,8]]},"abstract":"<jats:p>BACKGROUND: Allergic Rhinitis (AR), a prevalent condition in otorhinolaryngology, is mediated by Type 1 hypersensitivity through IgE, characterized by Type 2 inflammatory response and eosinophil infiltration in the nasal mucosa. Since AR disease exhibits significant heterogeneity in symptom severity, an objective assessment of AR severity may facilitate better individualized treatment. OBJECTIVE: To explore the changes in peripheral blood IL-9, Th9, and BAFF levels of allergic rhinitis (AR) in patients and the clinical significance associated with it. METHODS: A retrospective study selected 80 AR patients admitted from January 2022 to October 2022 as the case group, dividing them into mild and moderate-to-severe groups based on symptom scores. Concurrently, 50 patients without AR, who were treated for nasal bone fractures or underwent septoplasty, were selected as the group for comparison. Alterations in the expression levels of peripheral blood IL-9, Th9, and BAFF were analyzed and compared among the different groups. The diagnostic value of serum BAFF for the severity of AR was analyzed using the receiver operating characteristic (ROC) curve. RESULTS: Noticeable variations were observed in clinical variables among the three groups such as, total IgE levels, peripheral blood eosinophil count and proportion, TNSS, and VAS (P&lt; 0.05), while no statistically significant differences were observed in other variables (P&gt; 0.05). The comparison of IL-9, Th9, and BAFF among the three groups revealed statistically significant differences (P&lt; 0.05). Analysis using multivariate logistic regression revealed that IL-9 (OR = 2.365), Th9 (OR = 2.186), BAFF (OR = 2.307) were influencing factors of moderate-to-severe AR (P&lt; 0.05). The ROC curve indicated that the AUC for the diagnosis of moderate-to-severe AR by IL-9, Th9, BAFF were 0.770, 0.734, 0.761, respectively, and the combined detection AUC was 0.888, an area under the curve higher than individual testing. CONCLUSION: Changes in peripheral blood IL-9, Th9, and BAFF levels in AR patients may function as indicators to assess the level of severity in diagnostic procedures.<\/jats:p>","DOI":"10.3233\/thc-240756","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:43:41Z","timestamp":1722591821000},"page":"4571-4580","source":"Crossref","is-referenced-by-count":2,"title":["Changes in peripheral blood IL-9, Th9, and BAFF levels in patients with allergic rhinitis and their clinical implications"],"prefix":"10.1177","volume":"32","author":[{"given":"Fengjie","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenggang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"4","key":"10.3233\/THC-240756_ref1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/alr.23090","article-title":"International consensus statement on allergy and rhinology: Allergic rhinitis \u2013 2023","volume":"13","author":"Wise","year":"2023","journal-title":"Int Forum Allergy Rh."},{"issue":"11","key":"10.3233\/THC-240756_ref2","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1111\/all.15454","article-title":"Update on pathomechanisms and treatments in allergic rhinitis","volume":"77","author":"Zhang","year":"2022","journal-title":"Allergy."},{"issue":"11","key":"10.3233\/THC-240756_ref3","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1111\/all.15044","article-title":"Advances and highlights in allergic rhinitis","volume":"76","author":"Zhang","year":"2021","journal-title":"Allergy."},{"issue":"1","key":"10.3233\/THC-240756_ref4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaci.2019.06.049","article-title":"Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence","volume":"145","author":"Bousquet","year":"2020","journal-title":"J Allergy Clin Immun."},{"issue":"5","key":"10.3233\/THC-240756_ref5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11882-019-0860-8","article-title":"Th9 cells in allergic disease","volume":"19","author":"Angkasekwinai","year":"2019","journal-title":"Curr Allergy Asthm R."},{"issue":"4","key":"10.3233\/THC-240756_ref6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/all.12828","article-title":"Current and future biomarkers in allergic asthma","volume":"71","author":"Zissler","year":"2016","journal-title":"Allergy."},{"issue":"3","key":"10.3233\/THC-240756_ref7","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.5415\/apallergy.2021.11.e25","article-title":"Suppressive effect of dexamethasone on murine Th9 cell-mediated nasal eosinophilic inflammation","volume":"11","author":"Koyama","year":"2021","journal-title":"Asia Pac Allergy."},{"issue":"15","key":"10.3233\/THC-240756_ref8","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.3390\/ijms22157785","article-title":"Mechanisms governing anaphylaxis: Inflammatory cells, mediators, endothelial gap junctions and beyond","volume":"22","author":"Nguyen","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.3233\/THC-240756_ref9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/JIR.S350003","article-title":"Multiple-cytokine profiling: A novel method for early prediction of the efficacy of sublingual immunotherapy in allergic rhinitis patients","volume":"15","author":"Zhang","year":"2022","journal-title":"J Inflamm Res."},{"issue":"18","key":"10.3233\/THC-240756_ref10","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1080\/15384101.2021.1966961","article-title":"Roles of Clara cell 10-kD protein and type 2 innate lymphoid cells in allergic rhinitis","volume":"20","author":"Long","year":"2021","journal-title":"Cell Cycle."},{"key":"10.3233\/THC-240756_ref11","doi-asserted-by":"crossref","first-page":"108515","DOI":"10.1016\/j.intimp.2021.108515","article-title":"Circulating BAFF as novel biomarker in distinguishing chronic rhinosinusitis with nasal polyps endotypes and predicting postoperative recurrence","volume":"104","author":"Wang","year":"2022","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.3233\/THC-240756_ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2021.0570","article-title":"Allergic rhinitis: Diagnosis and management","volume":"83","author":"Siddiqui","year":"2022","journal-title":"Brit J Hosp Med."},{"issue":"12","key":"10.3233\/THC-240756_ref13","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1111\/all.14586","article-title":"Advances and novel developments in allergic rhinitis","volume":"75","author":"Meng","year":"2020","journal-title":"Allergy."},{"key":"10.3233\/THC-240756_ref14","doi-asserted-by":"crossref","first-page":"7783481","DOI":"10.1155\/2022\/7783481","article-title":"lncRNA FR215775 regulates Th2 differentiation in murine allergic rhinitis","volume":"2022","author":"Ma","year":"2022","journal-title":"J Immunol Res."},{"issue":"12","key":"10.3233\/THC-240756_ref15","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1111\/all.14632","article-title":"Advances and novel developments in mechanisms of allergic inflammation","volume":"75","author":"Han","year":"2020","journal-title":"Allergy."},{"issue":"3","key":"10.3233\/THC-240756_ref16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/0960327120958105","article-title":"Bisphenol A as a risk factor for allergic rhinitis in children","volume":"40","author":"Nalbantoglu","year":"2021","journal-title":"Hum Exp Toxicol."},{"key":"10.3233\/THC-240756_ref17","doi-asserted-by":"crossref","first-page":"783254","DOI":"10.3389\/fimmu.2022.783254","article-title":"BAFF Blockade Attenuates DSS-Induced Chronic Colitis via Inhibiting NLRP3 Inflammasome and NF-kappaB Activation","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol."},{"issue":"5","key":"10.3233\/THC-240756_ref18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.dld.2020.11.030","article-title":"B-cell activating factor (BAFF) expression is associated with Crohn\u2019s disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment","volume":"53","author":"Andreou","year":"2021","journal-title":"Digest Liver Dis."},{"issue":"12","key":"10.3233\/THC-240756_ref19","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1016\/j.sjbs.2021.08.044","article-title":"Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia","volume":"28","author":"Alturaiki","year":"2021","journal-title":"Saudi J Biol Sci."},{"issue":"2","key":"10.3233\/THC-240756_ref20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000094897","article-title":"B cell-activating factor is a novel diagnosis parameter for asthma","volume":"141","author":"Kang","year":"2006","journal-title":"Int Arch Allergy Imm."},{"issue":"15","key":"10.3233\/THC-240756_ref21","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.3390\/ijms22158173","article-title":"PM(2.5) Exacerbates Oxidative Stress and Inflammatory Response through the Nrf2\/NF-kappaB Signaling Pathway in OVA-Induced Allergic Rhinitis Mouse Model","volume":"22","author":"Piao","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.3233\/THC-240756_ref22","doi-asserted-by":"crossref","first-page":"872152","DOI":"10.3389\/fped.2022.872152","article-title":"Circulating C-X-C motif ligand 13 as a biomarker for early predicting efficacy of subcutaneous immunotherapy in children with chronic allergic rhinitis","volume":"10","author":"Cheng","year":"2022","journal-title":"Front Pediatr."},{"issue":"12","key":"10.3233\/THC-240756_ref23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ni.1677","article-title":"IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells","volume":"9","author":"Dardalhon","year":"2008","journal-title":"Nat Immunol."},{"issue":"6","key":"10.3233\/THC-240756_ref24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ni.1867","article-title":"The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation","volume":"11","author":"Chang","year":"2010","journal-title":"Nat Immunol."},{"issue":"7","key":"10.3233\/THC-240756_ref25","doi-asserted-by":"crossref","first-page":"e0131248","DOI":"10.1371\/journal.pone.0131248","article-title":"Association between the Interaction of Key Genes Involved in Effector T-Cell Pathways and Susceptibility to Develop allergic Rhinitis: A Population-Based Case-Control Association Study","volume":"10","author":"Zhang","year":"2015","journal-title":"Plos One."},{"issue":"9","key":"10.3233\/THC-240756_ref26","doi-asserted-by":"crossref","first-page":"14314","DOI":"10.18632\/oncotarget.15177","article-title":"Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th2, Th9, and Th17 responses and increasing the Treg response in a murine model","volume":"8","author":"Gu","year":"2017","journal-title":"Oncotarget."},{"issue":"2","key":"10.3233\/THC-240756_ref27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.anai.2009.11.043","article-title":"Serum interleukin 9 in allergic rhinitis","volume":"104","author":"Ciprandi","year":"2010","journal-title":"Ann Allerg Asthma Im."}],"container-title":["Technology and Health Care"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/THC-240756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:01:27Z","timestamp":1777615287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/THC-240756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":27,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3233\/thc-240756","relation":{},"ISSN":["0928-7329","1878-7401"],"issn-type":[{"value":"0928-7329","type":"print"},{"value":"1878-7401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}